Articles

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research

H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
University of Minnesota Medical Center, Minneapolis, MN, USA
CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA;Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI, USA
CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, FL, USA
Adult Bone Marrow Transplant, University Hospitals Bristol NHS Trust, Bristol, UK
Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, USA
Levine Cancer Institute, Atrium Health, Carolinas HealthCare System, Charlotte, NC, USA
Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA
Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA, USA
Division of Cell Therapy and Hematology, Department of Medicine, Duke University Medical Center, Durham, NC, USA
Blood and Cancer Centre, Starship Children’s Hospital, Auckland, New Zealand
Department of Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA
Department of Stem Cell Transplantation, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, TX, USA
Division of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan
Blood & Marrow Transplant Program, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA
Department of Internal Medicine, Mayo Clinic, MN, USA;Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
Division of Hematology and Oncology, Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX, USA
Department of Hematology, Inselspital, Bern University Hospital, Switzerland
Markey Cancer Center, University of Kentucky, Lexington, KY, USA
Loyola University Medical Center, Maywood, IL, USA
University of Kansas Medical Center, Westwood, KS, USA
City of Hope Comprehensive Cancer Center, Duarte, CA, USA
University of Miami, Miami, FL, USA
Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA, USA
Division of Hematology and Oncology, Washington University School of Medicine, St. Louis, MO, USA
Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden;Centre for Clinical Research Sormland, Uppsala University, Uppsala, Sweden
Vanderbilt University Medical Center, Nashville, TN, USA
Department of Pediatric Hematology, Oncology and Bone Marrow Transplant, British Columbia’s Children’s Hospital, The University of British Columbia, Vancouver, British Columbia, Canada
Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
Department of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, Manitoba, Canada
Tom Baker Cancer Centre, Calgary, Alberta, Canada
Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
Department of Hematology/Oncology, Isala Clinic, Zwolle, the Netherlands
Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, New York Medical College, Valhalla, NY, USA
Loyola University Chicago Stritch School of Medicine, Maywood, IL, USA
The Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE, USA
The Children’s Hospital at TriStar Centennial and Sarah Cannon Research Institute, Nashville, TN, USA
Division of Hematology, Oncology and Blood & Marrow Transplantation, Children’s Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, CA, USA
City of Hope Comprehensive Cancer Center, Duarte, CA, USA
Section of Hematology/Oncology, Department of Internal Medicine, Louisiana State University Health Shreveport, Shreveport, LA, USA
Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, NC, USA
Department of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA
Department of Hematology & Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA
Translational Cell Therapy Group, CLINTEC (Clinical Science, Intervention and Technology), Karolinska Institutet, Stockholm Sweden
Academische Ziekenhuis Maastricht, Maastricht, the Netherlands
Mayo Clinic Florida, Jacksonville, FL, USA
University of Chicago Medicine, Chicago, IL, USA
Blood & Marrow Transplant Center, Florida Hospital Medical Group, Orlando, FL, USA
UCLA Medical Center, Los Angeles, CA, USA
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA
QE II Health Sciences Centre, Dalhousie University, Halifax, Nova Scotia, Canada
Hospital Vall d’Hebron, Barcelona, Spain
Rush University Medical Center, Chicago, IL, USA
Christian Medical College, Vellore, India
Blood and Marrow Transplantation Program, Division of Hematology/Oncology, Department of Internal Medicine, The University of Michigan Medical School, Ann Arbor, MI, USA
Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC, USA
Division of Hematology-Oncology, Indiana University School of Medicine, Indianapolis, IN, USA
National Cancer Institute (NCI), Rockville, MD, USA
New York Presbyterian Hospital/Columbia University Medical Center, New York, NY, USA
UF Health Shands Children’s Hospital, Gainesville, FL, USA
Department of Advanced Medicine, Nagoya University Hospital, Nagoya, Japan
Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan
Division of Hematology/Oncology/Cell Therapy, Rush University, Chicago, IL, USA
Memorial Sloan Kettering Cancer Center, New York, NY, USA
Case Western Reserve University, Cleveland, OH, USA
CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
Division of Medical Oncology, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Department of Medicine, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA
Division of Hematology and Transplant Center, Mayo Clinic Rochester, Rochester, MN, USA
Blood and Marrow Transplant Program, University of Minnesota Medical Center, Minneapolis, MN, USA
Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota Medical Center, Minneapolis, MN, USA
CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
Vol. 105 No. 5 (2020): May, 2020 https://doi.org/10.3324/haematol.2019.220756